HCN2 and generalized epilepsy: This phenotype is clearly milder than the pharmacoresistant generalized epilepsy with tonic-clonic seizures with autosomal recessive inheritance associated with the HCN2 mutation (E515K) we previously reported (DiFrancesco et al., 2011).